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Patients with proteinuric kidney diseases often have
symptoms of salt and water retention. It has been
hypothesized that dysregulated sodium absorption is due to
increased proteolytic cleavage of epithelial sodium channels
(ENaCs) and increased Na,K-ATPase expression. Microarray
analysis identified a reduction in kidney corin mRNA
expression in rat models of puromycin aminonucleoside-
induced nephrotic syndrome and acute anti-Thy1
glomerulonephritis (GN). As atrial natriuretic peptide (ANP)
resistance is a mechanism accounting for volume retention,
we analyzed the renal expression and function of corin; a
type II transmembrane serine protease that converts pro-ANP
to active ANP. Immunohistochemical analysis found that
corin colocalized with ANP. The nephrotic and
glomerulonephritic models exhibited concomitant increased
pro-ANP and decreased ANP protein levels in the kidney
consistent with low amounts of corin. Importantly, kidneys
from corin knockout mice had increased amounts of renal
b-ENaC and its activators, phosphodiesterase (PDE) 5 and
protein kinase G II, when compared to wild-type mice.
A similar expression profile was also found in cell culture
suggesting the increase in PDE5 and kinase G II could
account for the increase in b-ENaC seen in nephrotic
syndrome and GN. Thus, we suggest that corin might be
involved in the salt retention seen in glomerular diseases.
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Clinical signs of volume retention are frequently observed in
patients with acute and chronic glomerular disease. Although
acute glomerulonephritis (GN) results mostly in a nephritic
syndrome, the nephrotic syndrome occurs mainly in minimal
change disease, membranous GN, and primary focal seg-
mental glomerulosclerosis. Both share common symptoms
such as proteinuria, as a result of glomerular damage, signs of
salt and volume retention presented as hypertension and/or
edema formation and hypercholesteremia. In addition, the
nephrotic syndrome presents hypoalbuminemia and intra-
vascular volume depletion as a cardinal feature.
It is generally agreed that volume retention observed in
nephrotic syndrome results primarily from a renal dysregula-
tion. Early in vivo micropuncture studies using experimental
animal models of GN or nephrotic syndrome localized the
site of impaired sodium excretion to the connecting tubule
and collecting duct (CD).1,2 The increase in Naþ absorption
observed in nephrotic syndrome and GN was shown to be
linked to aldosterone-independent activation of the epithelial
sodium channel (ENaC),3–8 and concomitant upregulation
of the basolaterally located sodium potassium ATPase (Na,
K-ATPase).4 Recently, new regulatory mechanisms have
emerged by the identification of proteolytical ENaC subunit
cleavage, which increases the open probability of the channel
three- to fivefold.9–12 Interestingly, the serine protease plasmin
recovered in the urine of nephrotic patients was shown to
activate ENaC. Proteolytical cleavage of ENaC may therefore
represent a potential mechanism that could account for the
increased Naþ reabsorption observed in proteinuric kidney
diseases. Aldosterone,13,14 vasopressin,15 nitric oxide,16 angio-
tensin II, or insulin-like growth factor14 which regulate sodium
reabsorption in the CD have also been proposed to have a
function in volume retention in proteinuric kidney diseases.
However, blockade of their specific pathways had no or only
minimal beneficial effects on salt retention.14
Atrial natriuretic peptide (ANP) is another important
factor proposed, which is highly produced in heart and in
various organs such as the kidney. Once released, binding to
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its receptor, the membrane-bound guanylyl cyclase stimulates
intracellular cyclic guanosine monophosphate (cGMP) pro-
duction. cGMP then activates cGMP-dependent phospho-
diesterases (PDEs) and cGMP-dependent protein kinases
(PKGs).17 ANP target organs are the kidney and blood vessels
leading to natriuresis, diuresis, and vasodilatation. Several
studies have demonstrated a marked renal resistance to
ANP,18,19 which was hypothesized to be an underlying
mechanism for volume retention in proteinuric disease.
The observed dysregulation was suggested to be mediated
through increased cGMP-specific PDE5 activity accelerating
the degradation of cGMP.18,19
Recently, corin, a type II transmembrane serine protease,
was found to be responsible for converting pro-ANP to active
ANP.20 Generation of corin-deficient (Cor/) mice con-
firmed corin as a rate-limiting enzyme for ANP maturation.21
Similar to ANP and guanylyl cyclase-A-deficient mice,
Cor/ mice developed hypertension that was exacerbated
by salt load and pregnancy.21
Volume retention in proteinuric kidney diseases is thought
to be multifactorial. In search of the origin, microarray
analysis comparing renal medullary gene expression levels in
rats with puromycin aminonucleoside (PAN)-induced
nephrotic syndrome and anti-Thy1 GN was performed,
and markedly reduced corin expression was identified in
experimental rat models when compared with controls.
Therefore, we aimed to perform a detailed renal localization
of corin, verified its expression levels in experimental models
of PAN and GN, and explored its function in the kidney by
analyzing the ANP signaling cascade using Cor/ mice and
cell culture experiments.
RESULTS
Renal function in PAN and GN
Rats injected either with the monoclonal antibody OX-7
(GN) or PAN developed proteinuria (control: 15±6 mg/24 h;
PAN: 539±99* mg/24h; GN: 199±24* mg/24 h; Po0.001)
and PAN-injected rats also displayed a nephrotic syndrome
with severe ascites. In both cases, plasma creatinine and urea
levels significantly increased when compared with control
rats (creatinine control: 0.17±0.03 mg/dl; PAN: 0.53±0.2*
mg/dl; GN: 0.36±0.13* mg/dl; urea control: 38±6 mg/dl;
PAN: 196±88* mg/dl; GN: 79±16* mg/dl; Po0.01),
whereas renal creatinine clearance and fractional sodium
excretion significantly decreased (glomerular filtrate rate
control: 3.91±1.3 ml/min; PAN: 1.14±0.6* ml/min; GN:
2.31±0.43* ml/min; FENa control: 0.22±0.03%; PAN:
0.07±0.02%*; GN: 0.18±0.03%; Po0.01).
Validation of monoclonal anti-corin antibody specificity
A monoclonal anti-corin antibody was produced and its
specificity was controlled by transfecting human embryonic
kidney (HEK) 293 cells with His-tagged full-length corin and
pcDNA3.1 (mock). Immunohistochemistry demonstrated
identical signals using anti-corin double labeled with anti-
His (Figure 1a and b). Preincubation of the antibody with the
respective antigen blocked the signal (not shown). Western
blot using the anti-corin and anti-His antibodies revealed a
main labeled band at B160 to 170 kDa only in corin
construct-transfected cells, but not in mock-transfected cells
(Figure 1c). Corin was first identified in the human heart,22
atrial tissue was tested for further immunohistochemical
verification of the specificity of our anti-corin antibody.
Expression was found in the plasma membrane and vesicles
of myocytes (Figure 1d).
Renal corin expression
Double staining procedures were then performed on rat
kidney sections to analyze the intrarenal distribution of corin.
Positive corin immunostaining was found in epithelial cells,
with segmental expression in the proximal tubule, thick
ascending limb (TAL), connecting tubule, and throughout
the CD. Highest expression level was observed in the medulla.
In the proximal tubule (identified by the brush border
membrane stained with phalloidin), corin staining was
found in the apical endocytic compartment (Figure 2a).
In TAL (identified by NKCC2 staining), corin was expressed
in vesicles around the nucleus and within the cytoplasm
(Figure 2b). Similarly, in CD (identified by aqua-
porin-2 staining) corin was localized evenly distributed in
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Figure 1 |Validation of monoclonal anti-corin antibody
specificity. (a and b) Double labeling of anti-corin (red, a) and
anti-His (green, b) on human embryonic kidney (HEK) 293 cells
transiently transfected with a His-tagged full-length corin
construct. Both signals are identical. (c) Western blot analysis of
corin (lanes 1 and 3) and mock (lanes 2 and 4)-transfected HEK
293 cells using anti-corin (lanes 1 and 2) and anti-His antibodies
(lanes 3 and 4). Both show a strong band at B170 kDa (asterisk).
(d) Indirect immunohistochemistry revealed a highly abundant
corin expression in heart tissue with a predominant localization at
the plasma membrane (arrowheads). In addition, positive staining
of intracellular vesicles near the plasma membrane is found.
Magnification: calibration bar¼ 10mm.
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cytoplasmic vesicles (Figure 2c). Interstitial cells were also
positive for corin.
Sites of renal ANP production
On rat kidney sections, in situ hybridization was performed
to establish the site(s) of renal ANP production. Within the
glomerulus, ANP mRNA was found to be produced in
podocytes (Figure 3a), whereas other glomerular cells
remained negative. Along the nephron, the proximal tubule,
identified by its brush border, showed weak staining for ANP
mRNA mainly in the S3 segment. Strongest ANP mRNA
signals were detected in TAL and in the connecting tubule/
CD system, as identified by their location within the kidney
(Figure 3b). ANP mRNA labeling was also detected along
the entire CD until the papillary tip (Figure 3c). Interstitial
cells of the renal medulla were stained for ANP as well.
As controls, ANP cRNA sense probes were applied simulta-
neously; no signal was generated (Figure 3d–f).
Immunohistochemical localization of ANP demonstrated
the typical expression pattern in heart cardiomyocyte vesicles
around the nucleus, confirming validity of the antibody
used (Figure 3g and h). In the kidney, however, ANP was
only detected in the medullary CD of the papillary tip
(Figure 3i–k). In addition, CD cells exhibited a heterogenous
pattern of cellular immunostaining, predominantly located in
vesicular structures of the cytoplasm and of the subapical
region in close proximity to the plasma membrane.
Changes in corin and ANP expression in PAN and GN
Microarray analysis of RNA isolated from the inner stripe
and inner medulla revealed strongly reduced corin mRNA
abundances in PAN- and GN-treated rats compared with that
of controls (Table 1).
Real-time PCR revealed that the expression levels of corin
mRNA in the renal cortex was slightly, but not significantly,
reduced in PAN and GN rats when compared with that of
control renal cortices. Concomitantly, levels of ANP mRNA
expression were significantly increased in renal cortices from
PAN and GN rats. A significant stronger reduction in corin
mRNA and concomitant increase in ANP mRNA expression
levels were detected in the medulla from PAN and GN rats
when compared with that of control rats (Table 1).
In the renal cortex, the amount of corin and pro-ANP
protein did not differ between PAN and GN rats when
compared with control rats. Values obtained for corin were as
follows: control, 100±16%; PAN, 78±6%; GN, 92±9%;
and those for pro-ANP were as follows: control, 100±10%;
PAN, 139±24%; GN, 99±12%. However, the amount of
corin protein was significantly reduced in the renal medulla
of PAN and GN rats (Figure 4a, control: 100±10%; PAN:
35±5%*; GN: 21±8%*; Po0.05) contrasting an increased
level of pro-ANP (Figure 4b; control: 100±23%; PAN:
214±25%*; GN: 191±13%*; *Po0.05). Consistent with
decreased pro-ANP into ANP conversion, PAN and GN rat
kidneys exhibited significantly less ANP than control kidneys
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Figure 2 | Immunohistochemical localization of corin in rat kidney. Double-labeling experiments of corin (red) and nephron segments
markers (green) using fluorescent phalloidin, anti-NKCC-2, and anti-aquaporin-2. (a) Corin is highly expressed in subapical vesicles of
the proximal tubule. In the merge image nuclear 4,6-diamidino-2-phenylindole stain is added. (b) Cytoplasmic vesicular expression is
shown in the thick ascending limb and (c) collecting duct of the renal medulla. Magnification: calibration bar¼ 20 mm.
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ANP AQP2 Merge
Figure 3 |Atrial natriuretic peptide (ANP) production and binding sites in the kidney and the heart. (a–c) ANP mRNA expression
obtained by in situ hybridization. (a) In the renal cortex, ANP mRNA labeling is shown in podocytes (arrowheads) and distal tubules.
(b) Typical formation of connecting tubules (circles) around an artery within a cortical region is presented. (c) Medullary collecting ducts
and interstitial cells labeled for ANP mRNA. (d–f) ANP mRNA sense probes were applied as a negative control showing corresponding
areas of the kidney. No signal is obvious. (g and h) Immunohistochemical detection of ANP protein in the heart atrium. ANP expression in
(g) low and in (h) greater detail image demonstrates the typical perinuclear vesicle staining. (i–k) Double labeling of ANP with aquaporin-2.
Localization of ANP protein is exclusively present in the medullary collecting duct within the papillary tip. Magnification: calibration bar¼ 20mm.
Table 1 |mRNA abundances of corin and ANP in renal cortex and medulla
Calculations of mRNA abundance±s.e.
Control PAN GN
Microarray
Corin 6419# 2531# 3625#
Cortex
Corin 1.00±0.20 0.66±0.15 0.76±0.20
ANP 1.00±0.72 6.64±1.75* 6.51±3.26*
Medulla
Corin 1.00±0.06 0.33±0.12* 0.37±0.12*
ANP 1.00±0.23 37.74±12* 20.75±6.91*
Abbreviations: ANP, atrial natriuretic peptide; GN, glomerulonephritis; mRNA, messenger RNA; PAN, puromycin aminonucleoside.
Medullary assessment of corin mRNA by Affymetrix microarray analysis. Normalized values are presented, detection #Po0.001. TaqMan analysis of cortical and medullary corin
and ANP. Control levels are set as 1=100%. Mean±s.e.; n=6; *Po0.005.
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(Figure 4c; control: 5.6±0.1 ng ANP/mg protein; PAN:
3.5±0.3# ng ANP/mg protein; GN: 3.7±0.2# ng ANP/mg
protein; #Po0.001).
Expression of ENaC, Na,K-ATPase, aquaporin-2, and ANP
signaling cascade in Cor/ mice
Corin was shown to play a key role in the processing of ANP.
This natriuretic peptide is known to act on the collecting duct.
Therefore we analyzed the protein levels of ENaC subunits,
Na,K-ATPase, AQP2 and ANP signaling from Cor/ mice.
Western blot analysis of enriched plasma membrane fractions
from whole kidney homogenate of Cor/ mice demonstrated a
significant increase in the amount of b-ENaC as compared with
that of wild-type (WT) kidneys (WT vs Cor/: b-ENaC 100±27
vs 296±43%*; Po0.001), whereas a- and g-ENaC, as well as
Na,K-ATPase, and aquaporin-2 remained unchanged (Figure 5a
and b). In accordance with these findings, immunohistochemistry
revealed a strong medullary increase in b-ENaC expression in
medullary kidney sections of Cor/ mice (Figure 5c).
Next, to identify mechanisms which could be responsible
for the augmented b-ENaC abundance observed in Cor/
mice, the expression levels of signaling components from the
ANP-transduction cascade were determined. Western blot
analysis revealed a strong increase in PDE5, phospho-PDE5,
and PKGII abundance in kidneys from Cor/ mice as
compared with that of WT counterparts (WT vs Cor/;
PDE5: 100±14 vs 272±20%*; phospho-PDE5: 100±25 vs
262±33%* and PKGII: 100±7 vs 245±18%*; Po0.05;
Figure 5a and b). Immunohistochemical studies also showed
a more intense immunostaining of PKGII in medullary CD
from Cor/ mice than in WT CDs (Figure 5c).
ANP inhibits agonist-induced aldosterone synthesis in
adrenal zona glomerulosa cells.23 In Cor/ mice, defective
ANP production could result in increased aldosterone
synthesis, and therefore account for the increase in b-ENaC.
Expression levels of components from the aldosterone-
induced signaling cascade were determined. Western blot
analysis revealed decreased Akt, phospho-Akt(S), phospho-
Akt(T), phospho-serum- and glucocorticoid-inducible kinase 1
(p-SGK1), and With No Lysine protein kinase1 (WNK1) in
kidneys of Cor/ mice, whereas WNK4 and neuronal precursor
cells expressed developmentally downregulated (Nedd) 4-2
remained unchanged (Cor/ in percent reduction from
WT mice; Akt: 74±17%*; phospho-Akt(S) 47±7%*;
phospho-Akt(T) 48±11%*; p-SGK1 81±7%*; WNK1
68±12%*; Po0.05, Supplementary Figure 1). Collectively,
these results argue against an aldosterone-dependent mecha-
nism in Naþ retention and therefore hypertension observed
in Cor/ mice.
Effects of cGMP reduction in mpkCCDcl4 cells on ANP
signaling
We hypothesized that the decline in cellular cGMP generation
could account for the augmented b-ENaC, PDE5, phospho-
PDE5, and PKGII abundance in Cor/ mice. To validate this
hypothesis, confluent mpkCCDcl4 cells were incubated with
500 mmol/l 3-isobutyl-1-methylxanthine and 100 mmol/l 8-
bromo-cGMP for 24 h and then maintained under fetal calf
serum-free medium for the next 0–24 h. The reduction in
cGMP content resulted in an increase in b-ENaC, PDE5,
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Figure 4 |Altered corin, pro-atrial natriuretic peptide (ANP)
and ANP expression in proteinuric kidney diseases.
(a) Western blot analysis of medullary corin expression levels.
Compared with controls strongly reduced expression levels are
present in puromycin aminonucleoside (PAN) and
glomerulonephritis (GN)-treated rats. (b) Increased medullary
pro-ANP levels in PAN- and GN-treated rats are demonstrated and
are in good agreement with reduced corin expression. (c) Tissue
ANP levels were determined by ELISA. Significantly reduced ANP
content is found in PAN- and GN-treated rats. Values are
mean±s.e.; n¼ 6 per group; *Po0.05 and #Po0.001.
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phospho-PDE5, and PKGII protein content (expressed in %
increase from time 0: b-ENaC þ 111±48%* (4 h),
þ 135±62%* (8 h), þ 108±38%* (24 h); PDE5 þ 275±
56%* (4 h), þ 360±72%* (8 h), þ 212±48%* (24 h);
phospho-PDE5 þ 363±48%* (4 h), þ 307±42%* (8 h),
þ 287±38%* (24 h); and PKGII þ 117±25%* (4 h),
þ 98±8%* (8 h), þ 173±35%* (24 h); Po0.05, Figure 6a).
Similar results were obtained when using 3-isobutyl-1-
methylxanthine only (data not shown). We next analyzed
whether augmented PDE5 or/and PKGII would result in
increased phosphorylation of PDE5 and in increased b-ENaC
expression level. mpkCCDcl4 cells were transfected with
PDE5 or/and PKG II constructs. Cells transfected with PDE5
exhibited increases in b-ENaC, phospho-PDE5, and PKGII
(in % increase from mock transfected cells: b-ENaC
þ 134±30%*; phospho-PDE5 þ 40±5%*; and PKGII
þ 107±21%*; Po0.05, Figure 6b); cells transfected
with PKGII had increased b-ENaC and phospho-PDE5
(in % increase from mock-transfected cells: b-ENaC
þ 517±48%*; phospho-PDE5 þ 78±12%*; Po0.05) and
cells double-transfected with PDE5 and PKGII constructs
exhibited increased levels of b-ENaC and phospho-PDE5
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Figure 5 |Alterations in the abundance of b-epithelial sodium
channel (ENaC) and atrial natriuretic peptide (ANP) induced
signaling components in Cor/ mice compared with
wild-type (WT) mice. (a) Representative western blots of b-ENaC
and phosphodiesterase (PDE)5, phospho-PDE5 (p-PDE5), cGMP-
dependent protein kinase (PKG)II and b-actin (as loading control)
are shown. Strongly increased abundance is found for b-ENaC,
PDE5, p-PDE5, and PKGII in Cor/ mice compared with WT
mice. (b) Corresponding densitometric evaluations of western
blot analysis on ENaC subunits, Na/K-ATPase (NKA), aquaporin-2
(AQP2) and on PDE5, p-PDE5, and PKGII. Values are mean±s.e.;
n¼ 5 per group; *Po0.05. (c) Immunohistochemical labeling of
kidneys from Cor/ mice show increased signal intensity of
b-ENaC and PKGII in medullary collecting duct cells compared
with WT mice. Magnification: calibration bar¼ 20 mm.
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Figure 6 |Alterations in expression levels of b-epithelial
sodium channel (ENaC) and atrial natriuretic peptide (ANP)
signaling components after cyclic guanosine monophosphate
(cGMP) reduction and phosphodiesterase (PDE)5 and
cGMP-dependent protein kinase (PKGII) overexpression in
mpkCCDcl4 cells. (a) Western blots of b-ENaC, PDE5, phospho-
PDE5 (p-PDE5), PKGII, and b-actin (as loading control) on
mpkCCDcl4 cells underwent reduction in cGMP for 0, 4, 8, and
24 h. Increases in b-ENaC, PDE5, p-PDE5, and PKGII abundance
are shown. (b) Western blots of b-ENaC, PDE5, p-PDE5, PKGII,
and b-actin (as loading control) on transiently transfected
mpkCCDcl4 cells using pcDNA3.1 (mock), PDE5, and PKGII
constructs. Transient transfection of PDE5 and PKGII results
in augmented b-ENaC abundance and transfection of PKGII
phosphorylates PDE5. Values are mean±s.e.; n¼ 8 per
experiment.
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(in % increase from mock-transfected cells: b-ENaC þ 548±
67%*; phospho-PDE5 þ 200±15%*; Po0.05).
Analysis of ANP signaling cascade in PAN and GN
Finally, western blot analysis of renal medulla-enriched
plasma membrane fractions from control rat and PAN and
GN rat renal medulla were undertaken to analyze the
expression levels of components of the ANP signaling.
Western blot analysis revealed a significant increased
expression levels of b-ENaC, PDE5, phospho-PDE5, and
PKGII proteins in the medulla from PAN and GN rat
kidneys compared with that of control rat kidneys (Figure 7,
b-ENaC control: 100±14%; PAN: 256±26%*; GN: 324±7%*;
Po0.05, PDE5 control: 100±19%; PAN: 354±46%*; GN:
221±10%*; Po0.05, phospho-PDE5 control: 100±20%;
PAN: 185±22%*; GN: 190±5%*; Po0.05, and PKGII
control: 100±19%; PAN: 267±40%*; GN: 257±20%*;
Po0.05).
DISCUSSION
In search of possible causes for volume retention in
proteinuric kidney disease, gene expression profiling
was performed in rat models of PAN-induced nephrotic
syndrome and acute anti-Thy1 GN using Affymetrix micro-
array analysis. Corin, a transmembrane spanning protease
responsible for converting pro-ANP into ANP, was identified
to be markedly reduced in PAN and GN. Corin appears to be
an interesting candidate, as a number of studies proposed the
hypothesis of a dysregulated renal ANP system, which could
account for the salt retention observed in PAN.18,19
We produced an anti-corin antibody, which exhibited
similar cardiac expression pattern as in the pioneer study of
Yan et al.20 In addition, we identified positive corin
immunostaining in plasma membranes from rat cardiac
myocytes, which is in agreement with the hypothesis of pro-
ANP conversion at the cell surface. Corin was also detected in
vesicles of the proximal tubule, TAL and CD, and medullary
interstitial cells. Similarly, ANP exhibited an analogous
intrarenal pattern of mRNA expression, but the ANP protein
could only be detected in CD segments from the medulla.
We have no clear explanation for the lack of ANP protein
expression in nephron segments exhibiting significant ANP
mRNA levels. Despite the high mRNA expression, it cannot
be excluded that in contrast to cardiac myocytes, ANP
protein processed in podocytes, proximal tubules, and TAL is
rapidly secreted, and therefore its expression remains under
the detection limit. However, highest protein expression level
of ANP was found in medullary CD and is in agreement with
most prominent expression of the ANP receptor.24 Earlier
studies demonstrated that the inner medullar CD is the main
site of action of atrial peptides, although ANP actions
were demonstrated on multiple nephron segments as well.
Furthermore, the critical function of the distal nephron
segments in ANP-induced natriuresis was well demonstrated
in natriuretic peptide receptor overexpressing mice.25
Both, acute anti-Thy1 GN and PAN-induced nephrotic
syndrome show strongly reduced corin expression, which
resulted in augmented pro-ANP and diminished conversion
into active ANP. These data suggest that, as in the heart,22
corin may function as a pro-ANP cleavage protease. Released
ANP binds to the membrane-bound guanylyl cyclase and
thereby modulates cellular functions mediated through the
intracellular second messenger cGMP, which in turn regulates
several target enzymes.17,26 Most of the known cGMP effects
are mediated by the activation of cGMP-dependent PKGs,
cGMP-regulated ion channels, or by the regulation of cGMP-
dependent PDEs. The increase in cGMP is terminated by
the action of cGMP-degrading PDEs. In many cell types,
PDE5 has a major function in cGMP hydrolysis.27 In intact
cells, activation of PDE5 induced its phosphorylation at a
conserved serine residue by PKG. Thus, cGMP response is
determined by the ratio of cGMP-forming and -degradating
enzymes.
We used Cor/ mice to analyze the function of down-
regulated corin observed in proteinuric kidney diseases.
Cor/ mice exhibited increased pro-ANP associated with
deficient ANP levels as well as hypertension,24 both were
shown to appear in proteinuric kidney diseases. Most
effects were expected to occur in the medulla. Interestingly,
Control
β-ENaC
PDE5
p-PDE5
PKGII
%
 o
f c
on
tro
l
500
400
300
200
100
*
*
*
*
* *
*
*
β-ENaC PDE5 PKGIIp-PDE5
β-Actin
PAN GN kDa
- 100
- 100
-   75
-   75
-   75
-   50
Figure 7 |Alterations in abundance of b-epithelial sodium
channel (ENaC) and atrial natriuretic peptide (ANP) signaling
components in proteinuric kidney diseases. Western blots
of medullary b-ENaC, phosphodiesterase (PDE)5, phospho-PDE5
(p-PDE5), cGMP-dependent protein kinase (PKG)II and b-actin
(as loading control). Compared with controls strongly increased
expression levels are present in puromycin aminonucleoside
(PAN) (gray bar) and glomerulonephritis (GN) (white bar) rats for
all parameters analyzed. Densitometric evaluations are presented
below. Values are mean±s.e.; n¼ 5 per group; *Po0.05.
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Cor/ mice exhibited a significant increase of the b-ENaC
subunit expression in medullary CD. Similarly, aldosterone
and vasopressin, differently upregulate the a-, and/or b- and
g-ENaC subunit level, respectively.28 Patients with Liddle
syndrome, having a mutation in the PY-motif of the
b-subunit, suffer from hypertension through decreased
internalization of ENaC.29 Therefore, it can be assumed that
the increase in plasma membrane b-ENaC following ANP
deficiency could result in an increased cell surface ENaC
expression, as has been reported in proteinuric animal
models.3,5,6 Exploring the ANP-induced signaling cascade in
Cor/ mice, we found that PDE5, phospho-PDE5, and
PKGII were shown to be unexpectedly increased, suggesting
that the dysregulation in the signal transduction might be
upstream of both signaling proteins.
As a result of corin deficiency, plasma cGMP concentra-
tion and therefore urinary cGMP excretion are significantly
reduced as has been shown for membrane-bound guanylyl
cyclase A-deficient mice.30 Similarly, PAN rats exhibited
reduced urinary cGMP excretion.18 Therefore, we hypothe-
sized that the reduction in cGMP could result in an increase
of PDE5, PKGII, and concomitant phosphorylation of PDE5.
In accordance with this hypothesis, reducing the cGMP
content in mpkCCDcl4 cells led to the upregulation of
PDE5, PKGII, and PKGII-induced phospho-PDE5. Similar
paradoxical mechanisms are also observed in Cor/ mice
and in experimental models of proteinuric rats. However,
further studies will be needed to elucidate the molecular
mechanism underlying the cGMP regulatory pathway.
Compartmentation and compartment-specific regulation of
PDE5 by PKG was shown to allow selective cGMP-mediated
regulation of platelet functions.31 Transient transfection of
mpkCCDcl4 cells with PDE5 and PKGII constructs evidenced
specific interaction between both proteins in terms of
PDE5-phosphorylation by PKGII. Both, PDE5 and PKGII
share similar effects on b-ENaC activation. Nie et al.32
reported that 8-pCPT-cGMP stimulates ENaC activity using
ENaC-transfected oocytes. However, early patch-clamp
studies showed that cGMP and cGMP-induced PKG reduces
Naþ absorption by inhibiting an amiloride-sensitive cation
channel with a channel conductance of 28 pS,33 suggesting
that different channels can be activated following ANP
administration or reduction.
In addition to PKGII, elevated PDE5 itself contributes to
salt retention by decreasing intracellular cGMP levels, which
is the mediator of natriuretic factors such as nitric oxide.
PDE5 inhibition was shown to ameliorate renal damage and
reduce systolic blood pressure.34 Therefore, a central function
for corin, being at the beginning of the cascade must be
suggested. In the past, controversial results regarding ANP on
sodium and fluid transport mechanisms were reported. Some
studies demonstrated a decrease in Naþ transport and
vasopressin-stimulated water transport,35–37 whereas others
could not confirm these results.37,38 ANP may however
influence salt and water excretion also through its impact on
aldosterone synthesis. ANP normally inhibits aldosterone
production in adrenal glands.39 In contrary to the assumed
augmented aldosterone level, the observed diminished
renal expression of aldosterone-induced signaling cascade
in Cor/ mice rather argue for a reduced aldosterone
action that is associated with augmented ANP signaling
components.
In summary, proteinuric kidney diseases, such as the
nephrotic syndrome and acute GN, exhibit common
dysregulated mechanisms mainly in the CD system. One of
them involves the reduction in corin expression level, a pro-
ANP-converting protease, leading to increased levels of ANP
signaling components. Augmented PDE5 and PKGII in turn
increase b-ENaC abundance and may also influence other
renal transporter and channels. These findings therefore
strongly suggest that corin has a key function in the control
of Naþ and water absorption in proteinuric kidney diseases.
MATERIALS AND METHODS
Animals and experimental protocol
Male Wistar rats (n¼ 30) weighing between 180 and 200 g were
obtained from Charles River. Animals were kept under standard
conditions and had free access to standard chow and tap water. Anti-
Thy1 acute GN and PAN-induced nephrotic syndrome was
elicited by injecting intravenously a monoclonal antibody OX-7
(1 mg/kg body weight in phosphate-buffer saline, pH 7.5)5 or PAN
(Sigma-Aldrich, 150 mg/kg body weight in 0.9% NaCl), respectively.
For control rats, phosphate-buffer saline was injected as a vehicle.
To allow urine collection, animals were kept in metabolic cages 24 h
before and 6 days after injection. Two identical sets of animals were
studied (n¼ 18) for biochemical and (n¼ 18) for immunohisto-
chemical approaches. At the end of the experiment, animals
were anesthetized and kidneys were removed or perfusion-fixed.
In addition, kidneys of five WT and five Cor/ mice21 were used for
biochemical and immunohistochemical analysis. The experiments
were conducted in accordance to the German Law for the protection
of animals.
Cell culture and transfection studies
HEK 293 cells were cultured at 371C in 95% air/5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 4.5 g/l
glucose, 10% fetal bovine serum, penicillin (100 U/ml), and
streptomycin (100 mg/ml). Cortical CD mpkCCDcl4 cells were grown
in defined medium as described previously.40 In brief, growth
medium was composed of equal volumes of Dulbecco’s modified
Eagle’s medium and Ham’s F12, 60 nmol/l Na
þ selenate, 5 mg/ml
transferrin, 50 nmol/l dexamethasone, 1 nmol/l triiodothyronine,
10 ng/ml epidermal growth factor, 5 mg/ml insulin, 2% fetal bovine
serum, and 100 mg/ml penicillin/streptomycin. Cells were grown
in a 5% CO2/95% air atmosphere at 371C.
HEK 293 cells or mpkCCDcl4 cells were transfected either with
the pcDNA3.1 alone (mock; Invitrogen) or pcDNA3.1-rcorin
containing full-length rat corin, or the pcDNA3-Zeo-hPDE5A41
containing full-length human PDE5, pIRES2-EGFP-rPKGII contain-
ing full-length rat PKGII and/or pcDNA3-bPKGII42 containing
full-length bovine PKGII. Transient transfection of plasmids was
performed using FuGENE 6 transfection reagent (Roche Diagnostics,
Mannheim, Germany) according to manufacturer’s instruction.
Cells were washed and lysed in RIPA buffer containing 25 mmol/l
Tris-HCl pH 7.6, 150 mmol/l NaCl, 1% NP-40, 1% sodium
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deoxycholate, 0.1% SDS and 5 mmol/l CaCl2 supplemented with
protease inhibitor cocktail (Roche Diagnostics). After a clearing
centrifugation step, lysates were loaded on SDS-polyacrylamide gel
electrophoresis and western blot analysis was performed.
mpkCCDcl4 cells were also incubated with either 500 mmol/l
3-isobutyl-1-methylxanthine (Sigma-Aldrich) containing 100 mmol
8-bromo-cGMP (Sigma-Aldrich) or 3-isobutyl-1-methylxanthine
alone for 24 h. After washing, cells were incubated with fetal calf
serum, insulin and dexamethasone-free growth medium for 0, 4, 8
and 24 h. Cells were harvested, lysed in RIPA buffer and finally
western blot analysis was performed.
Urine analysis
Serum and urine electrolytes were determined by indirect ion-selective
electrode measurements (Modular Analytics, Roche Diagnostics).
Blood urea nitrogen was quantified enzymatically and serum creatinine
concentration was measured by the kinetic Jaffe´-method using routine
automated methods (Modular Analytics). Creatinine clearance and
fractional sodium excretion were calculated using standard equations.
Total urinary protein concentrations were measured with standardized
autoanalyzer methods (Hitachi 747, Hitachi 911; Hitachi, Japan, and
STA analyzers; Roche Diagnostics). Urinary pro-ANP excretion was
determined by western blot analysis.
Microarray analysis
Total RNA was isolated from inner medulla and inner stripe of control,
PAN and GN rats (n¼ 4 per group) using RNeasy Mini kit (Qiagen,
Hilden, Germany) and combined per group. Quality of total RNA was
checked by analysis on a LabChip (Agilent Technologies, Bo¨blingen,
Germany). Then, RNA was transcribed into cDNA and used to
synthesize biotin-labeled cRNA. Fifteen micrograms of fragmented
cRNA was hybridized to the rat genome 230 2.0 Array (Affymetrix,
Santa Clara, CA, USA) for 16 h at 451C. Raw gene expression data
were processed with Microarray Suite 5.0 software (Affymetrix) accord-
ing to manufacturer’s recommendations. Text files were exported
for the intensity information for each interrogating oligonucleotide
and deposited in the NCBI database of gene expression data (GEO,
accession number GSE 7103). The data were normalized to account
for variability in hybridization and other hybridization artefacts.
Immunohistochemical studies
Immunohistochemical studies were performed on rat tissue sections
or on HEK 293 cells grown on glass coverslips. Rats were anesthetized by
an intraperitoneal injection of sodium pentobarbital (0.06 mg/g body
weight). Kidneys were then in vivo perfused through the abdominal
aorta using 3% PFA dissolved in phosphate-buffer saline. Kidneys of
mice were removed and immersion fixed. For cryostat sectioning, tissues
were protected from freezing artifacts by 800 mOsm sucrose/phosphate-
buffer saline, shock-frozen and stored at 801C. For detection of corin
monoclonal and polyclonal antibodies directed against the N-terminus
were produced as described (procedure modified from Brodsky et al.43)
and characterized. In addition, we used well-characterized antibodies
to the following proteins: His-tag (MoBiTec, Go¨ttingen, Germany),
pro-ANP/ANP (Abcam (Cambridge, MA, USA) and Phoenix Pharma-
ceuticals (Mannheim, Germany)), b-actin (Sigma-Aldrich), a, b, gENaC,6
aNa/K-ATPase (Upstate, Lake Placid, NY, USA), anti-PDE5 and anti-Akt
antibodies (Cell Signaling, Danvers, MA, USA), anti-WNK1 and anti-
WNK4 (Biotrend, Ko¨ln, Germany), anti-phospho-SGK1 (Epitomics,
Burlingame, CA, USA), anti-Nedd4-2 (Upstate), anti-PKGII,44 and
anti-phospho-PDE5.41 In double-staining experiments, segments
were identified using phalloidin for actin filaments marking the
brush border of the proximal tubule, anti-NKCC-2 antibody5 for
TAL, and anti-aquaporin-2 (Santa Cruz Biotechnology, Heidelberg,
Germany) for the connecting tubule/CD system. Sections were
blocked, incubated with the respective primary antibody followed by
incubation with suitable cy-2- or cy-3-coupled secondary antibodies
(Dianova, Hamburg, Germany). In double-labeling experiments, the
primary antibodies were administered consecutively. Nuclei were
stained blue with 40,6-diamino-2-phenylindole. Sections and cells
were analyzed using a confocal scanning microscope (TCS SP-2,
Leica Microsystems, Wetzlar, Germany).
Western blot analysis
Preparations of cortical and medullary membrane fractions were
performed as described.5 Total protein concentration was measured
using a protein assay kit (BCA; Pierce, Rockford, IL, USA). SDS gel
electrophoresis was performed, and proteins were transferred to
nitrocellulose membranes and stained with 0.1% Ponceau red as a
loading control. After incubation with blocking reagent, membranes
were probed with primary antibodies described above and then
exposed to horseradish peroxidase-conjugated secondary antibodies
(DAKO, Hamburg, Germany). Immunoreactive bands were visualized
using an enhanced chemiluminescence kit, exposured to X-ray films
(Amersham Pharmacia, Freiburg, Germany) and analyzed using
BIO-PROFIL Bio-1D image software (Vilber Lourmat, Marne-la-Valle´e,
France). Finally, data of membrane fraction were normalized for
b-actin expression. All experiments were replicated at least two times.
ELISA
Rat ANP was detected in whole kidney homogenate using an
commercially available ANP ELISA kit (Assaypro, St Charles, MO,
USA). Assay was performed according to manufacturer’s instruction.
RNA isolation, reverse transcription, and real-time PCR
Total RNA was extracted from kidney cortices and medulla
using RNeasy Mini kit (Qiagen), and treated with DNase I
(Invitrogen). Reverse transcription was performed using Sensiscript
RT kit (Qiagen). TaqMan Gene Expression Assay for corin
Rn00711035_m1 and for ANP Rn00561661_m1 was used and the
experiment was performed according to the manual provided by
Applied Biosystem (Foster City, CA, USA). Threshold cycle (Ct)
values were set in the linear phase of exponential amplification. The
difference between values obtained for corin or ANP and that of the
housekeeping gene GAPDH (DCt) was calculated and compared
between control, PAN, and anti-Thy1 GN groups.
In situ hybridization
The mRNA of ANP was explored by in situ hybridization using
digoxigenin-labeled riboprobes (Roche Diagnostics). The 458 bp
coding sequence of ANP was cloned into the TOPO 2.1 vector
(Invitrogen). Sense and antisense probes were generated by in vitro
transcription of the corresponding cDNAs. In situ hybridization was
performed on paraffin sections according to an established
protocol.45
Presentation of data and statistical analysis
Quantitative data are presented as mean±s.e. For statistical
comparison, the Mann–Whitney rank-sum test was used. *P-values
of less than 0.05 and #P-values of less than 0.001 were considered
statistically significant.
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